Related Experiment Video
Updated: Mar 25, 2026

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
The role of the gut microbiome in nicotine withdrawal and dependence
Eda Koseli1, Katarzyna M Tyc2,3, Belle Buzzi1
1Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond VA 23298, United States.
Introduction:
Smoking is considered a global pandemic, with more than 1.3 billion people being active smokers. Increasing evidence suggests that nicotine exposure can lead to changes in the gut microbiome, increases in permeability, and impaired mucosal immune responses in the gastrointestinal tract. However, the literature on behavioral aspects of nicotine-microbiome interaction, such as dependence and withdrawal, is limited. In this study, we used homologous fecal material transplants (FMT) to modify the gut microbiome and its impact on the intensity of nicotine withdrawal in mice.
Methods:
We used osmotic minipumps (MPs) as an application of chronic nicotine for 15 days and orally gavaged FMT 2x a day to the mice. We assessed the nicotine withdrawal by measuring the number of somatic signs and anxiety-like behaviors at 24 h and 1 week after the mini pump removal. Fecal samples were also collected points to identify the gut microbiome changes.
Results:
Fecal transplants reduced the number of somatic signs and anxiety-like behaviors in nicotine-treated mice up to a week after the removal of MPs. The shotgun metagenomic results of the fecal samples from 24 h after MP removal time point show altered gut microbiome with a significant shift in the species composition between the nicotine-treated and its homologous FMT treatment.
Conclusions:
Our results indicate that under our experimental conditions, fecal transplant can reduce the severity of nicotine withdrawal. This suggests that interactions along the gut-brain axis are important for the development of nicotine dependence and might help lower the risk of cancer and other serious health problems in humans.
Implications:
This report shows for the first time that the gut microbiome may modulate nicotine withdrawal intensity in mice. Homologous fecal material transplants (FMT) prevented nicotine-induced gut microbiome dysbiosis and consequently reduced withdrawal severity in mice. These results may have important implications in the management of smoking cessation.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
Gut-Brain Axis
The Oral Microbiota
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

